Hernia Mesh (Medtronic/Covidien-Ethicon) Lawsuit

Hernia mesh lawsuits cover claims that implanted mesh — including Ethicon’s Symbotex barrier mesh (the “Covidien” brand, now part of Medtronic’s surgical portfolio) — failed to warn of serious complications such as bowel adhesions and obstruction (per complaints and the jury verdict). Federal cases are consolidated in MDL 3029 in the District of Massachusetts, with individual cases also proceeding in state courts (per firm pages). In August 2026 the first MDL bellwether jury returned a $77M compensatory verdict for the plaintiff and an $11M loss-of-consortium verdict for his spouse — $88M in total, described by the plaintiff firm as the largest compensatory verdict in the 15-year history of mesh litigation; the case resolved at $88M and a judge may still trim the verdict on post-trial motions (per the plaintiff law firm’s announcement and Law360). The next bellwether trial is set for January 2027 (per AboutLawsuits). We track the public record — we do not promise or predict outcomes.

Status of the science / claims: The claim is that the Symbotex barrier mesh was marketed with an anti-adhesion barrier that deteriorated sooner than expected, and that serious complications such as bowel adhesions and obstruction followed (per the jury verdict and the plaintiff firm’s account). Medtronic denies liability and maintains the products are safe when used as intended (per the plaintiff firm’s account of the defense position).